Company News

bioMérieux and JMI Laboratories (JMI) are announcing a six-year partnership to undertake collaborative projects evaluating the performance and increasing potential of rapid and innovative microbiology diagnostics as important tools in the battle against AMR.

At bioMérieux, we support the inclusion, well-being and development of our team members and are committed to creating a culture of belonging and acceptance where all feel respected, supported and included.

We are committed to play our part and as every gesture counts to change the game, we have implemented a number of concrete actions in line with our CSR objectives.

bioMérieux has developed a MONKEYPOX R-GENE® PCR kit. Available for research use only (RUO), this kit can easily be used by laboratories around the world.

bioMérieux is making a $5 million investment in InDevR, and will be the exclusive distributor in Europe of VaxArray®, a state-of-the-art vaccine quality control platform developed by the American company.